[NBIX] YoY Quarter Result on 31-Dec-2021 [#Q4]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
11-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -132.44%
YoY- -102.10%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 515,200 412,000 312,000 247,900 244,100 131,492 94,517 32.64%
PBT 198,200 117,900 -13,800 41,700 38,600 18,808 6,894 74.98%
Tax 50,500 28,900 -6,500 -306,200 4,600 730 6,686 40.05%
NP 147,700 89,000 -7,300 347,900 34,000 18,078 6,894 66.61%
Tax Rate -25.48% -24.51% - 734.29% -11.92% -3.88% -96.98% -
Total Cost 367,500 323,000 319,300 -100,000 210,100 113,414 87,623 26.97%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 28.67 21.60 -2.34 140.34 13.93 13.75 7.29 25.62%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 1.50 0.92 -0.08 3.72 0.37 0.20 0.08 62.95%
EPS Diluted 1.44 0.88 -0.08 3.58 0.35 0.19 0.07 65.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.